1h Free Analyst Time
The emergency contraceptive pills market is forecasted to grow by USD 258.4 million during 2024-2029, accelerating at a CAGR of 4.5% during the forecast period. The report on the emergency contraceptive pills market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in number of initiatives to create awareness, increase in unplanned pregnancies, and ease of online purchase.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The emergency contraceptive pills market is segmented as below:
By Distribution Channel
- Retail stores
- Online stores
By Type
- Combination pills
- Progesterone pills
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the emergency contraceptive pills market covers the following areas:
- Emergency Contraceptive Pills Market sizing
- Emergency Contraceptive Pills Market forecast
- Emergency Contraceptive Pills Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Distribution Channel
9 Market Segmentation by Type
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global emergency contraceptive pills market: AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is importance of family planning."
According to the report, one of the major drivers for this market is the rise in number of initiatives to create awareness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Afaxys Pharma LLC
- Bayer AG
- Combe Inc.
- Foundation Consumer Healthcare LLC
- Gedeon Richter Plc
- HLL Lifecare Ltd.
- Knoll Healthcare Pvt. Ltd.
- Laboratoire HRA Pharma SAS
- Lupin Ltd.
- Mankind Pharma Ltd.
- Morepen Laboratories Ltd.
- Perrigo Co. Plc
- Pfizer Inc.
- Piramal Enterprises Ltd.
- Sun Pharmaceutical Industries Ltd.
- Syzygy Healthcare LLC
- Teva Pharmaceutical Industries Ltd.
